Cue Health Closes $100M Series C Funding Back to HomeSAN DIEGO, CA, Cue Health announced the close of its Series C financing round, raising $100 million in new capital.

Cue Health Inc. ("Cue"), a healthcare technology company, announced today the close of its Series C financing round, raising $100 million in new capital.

Investors in Cue's Series C include Menlo Park-based Decheng Capital, Foresite Capital, Madrone Capital Partners, Johnson & Johnson Innovation - JJDC, Inc., ACME Capital and other investment firms.

Proceeds from the financing will be used to complete development, validation, and scale-up of manufacturing of the Cue Health Monitoring System and Cue Test Cartridges.

Goldman Sachs & Co. LLC acted as exclusive placement agent for the Series C financing. | To read full story, visit https://startuparound.com/read/1591966904.9874167/Cue-Health-Closes-$100M-Series-C-Funding?ref=audio_experience